Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 1304

    Article Cited by others

ORIGINAL ARTICLE

Saliva α-synuclein and a high extinction coefficient protein: A novel approach in assessment biomarkers of Parkinson's disease

Al-Nimer Marwan S. M., Mshatat Sabah F, Abdulla Hajer I

Year : 2014| Volume: 6| Issue : 12 | Page no: 633-637

   This article has been cited by
 
1 Quantitative metabolomics of saliva using proton NMR spectroscopy in patients with Parkinsonís disease and healthy controls
Sadhana Kumari,Vinay Goyal,S. Senthil Kumaran,S.N. Dwivedi,Achal Srivastava,N.R. Jagannathan
Neurological Sciences. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Methods for detecting toxic a-synuclein species as a biomarker for Parkinsonís disease
Darren M. OíHara,Suneil K. Kalia,Lorraine V. Kalia
Critical Reviews in Clinical Laboratory Sciences. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
Giovanni Schepici,Serena Silvestro,Oriana Trubiani,Placido Bramanti,Emanuela Mazzon
Brain Sciences. 2020; 10(4): 245
[Pubmed]  [Google Scholar] [DOI]
4 Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinsonśs Disease
Marisa Cressatti,Lamin Juwara,Julia M. Galindez,Ana M. Velly,Eva S. Nkurunziza,Sara Marier,Olivia Canie,Mervyn Gornistky,Hyman M. Schipper
Movement Disorders. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Salivary alpha-synuclein as a biomarker for Parkinsonís disease: a systematic review
Anastasia Bougea,Christos Koros,Leonidas Stefanis
Journal of Neural Transmission. 2019;
[Pubmed]  [Google Scholar] [DOI]
6 Salivary Biomarkers for Alzheimerís Disease and Related Disorders
Nicholas J. Ashton,Mark Ide,Henrik Zetterberg,Kaj Blennow
Neurology and Therapy. 2019; 8(S2): 83
[Pubmed]  [Google Scholar] [DOI]
7 Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinsonís Disease
Fen Xie,Xiaoya Gao,Wanlin Yang,Zihan Chang,Xiaohua Yang,Xiaobo Wei,Zifeng Huang,Huifang Xie,Zhenyu Yue,Fengli Zhou,Qing Wang
ACS Chemical Neuroscience. 2019;
[Pubmed]  [Google Scholar] [DOI]
8 a-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinsonís disease
Zhentang Cao,Yufeng Wu,Genliang Liu,Ying Jiang,Xuemei Wang,Zhan Wang,Tao Feng
Neuroscience Letters. 2019; 696: 114
[Pubmed]  [Google Scholar] [DOI]
9 Skin Fibroblasts as the Object for Clinical Diagnosis of Parkinsonís Disease in Persons of Different Ages
V. A. Zuev,A. S. Dyatlova,N. S. Liníkova,I. M. Kvetnoi,N. N. Belushkina,V. A. Palítsev
Bulletin of Experimental Biology and Medicine. 2019; 167(1): 177
[Pubmed]  [Google Scholar] [DOI]
10 Oligomeric a-synuclein is increased in basal tears of Parkinsonís patients
Sarah F Hamm-Alvarez,Curtis T Okamoto,Srikanth R Janga,Danielle Feigenbaum,Maria C Edman,Daniel Freire,Mihir Shah,Raveena Ghanshani,Wendy J Mack,Mark F Lew
Biomarkers in Medicine. 2019;
[Pubmed]  [Google Scholar] [DOI]
11 Salivary alpha-synuclein in the diagnosis of Parkinsonśs disease and Progressive Supranuclear Palsy
Giorgio Vivacqua,Antonio Suppa,Romina Mancinelli,Daniele Belvisi,Andrea Fabbrini,Matteo Costanzo,Alessandra Formica,Paolo Onori,Giovanni Fabbrini,Alfredo Berardelli
Parkinsonism & Related Disorders. 2019;
[Pubmed]  [Google Scholar] [DOI]
12 Proteome characterization in various biological fluids of Trypanosoma brucei gambiense-infected subjects
Julien Bonnet,Camille Garcia,Thibaut Leger,Marie-Pauline Couquet,Philippe Vignoles,Gedeao Vatunga,Joseph Ndungśu,Clotilde Boudot,Sylvie Bisser,Bertrand Courtioux
Journal of Proteomics. 2018;
[Pubmed]  [Google Scholar] [DOI]
13 Salivary biomarkers for the diagnosis and†monitoring of neurological diseases
Raymond Farah,Hayat Haraty,Ziad Salame,Youssef Fares,David M. Ojcius,Najwane Said Sadier
Biomedical Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
14 Detection of a-Synuclein in Saliva: The Importance of Preanalytical Assessment
Giorgio Vivacqua,Romina Mancinelli,Daniele Belvisi,Antonio Suppa,Alfredo Berardelli
Movement Disorders. 2018; 33(6): 1029
[Pubmed]  [Google Scholar] [DOI]
15 The Exosomal/Total a-Synuclein Ratio in Plasma Is Associated With Glucocerebrosidase Activity and Correlates With Measures of Disease Severity in PD Patients
Silvia Cerri,Cristina Ghezzi,Maria Sampieri,Francesca Siani,Micol Avenali,Gianluca Dornini,Roberta Zangaglia,Brigida Minafra,Fabio Blandini
Frontiers in Cellular Neuroscience. 2018; 12
[Pubmed]  [Google Scholar] [DOI]
16 Saliva biomarkers in neurological disorders: A ďspitting imageĒ of brain health?
Emma Louise Walton
Biomedical Journal. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Peripheral Biomarkers for Early Detection of Alzheimerís and Parkinsonís Diseases
Thein Than Htike,Sachin Mishra,Sundramurthy Kumar,Parasuraman Padmanabhan,BalŠzs GulyŠs
Molecular Neurobiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
18 Evaluation of salivary heme oxygenase-1 as a potential biomarker of early Parkinsonśs disease
Wei Song,Vimal Kothari,Ana M. Velly,Marisa Cressatti,Adrienne Liberman,Mervyn Gornitsky,Hyman M. Schipper
Movement Disorders. 2018;
[Pubmed]  [Google Scholar] [DOI]
19 Saliva Liquid Biopsy for Point-of-Care Applications
Katri Aro,Fang Wei,David T. Wong,Michael Tu
Frontiers in Public Health. 2017; 5
[Pubmed]  [Google Scholar] [DOI]
20 The Systemic Synuclein Sampling Study: toward a biomarker for Parkinsonśs disease
Naomi P Visanji,Brit Mollenhauer,Thomas G Beach,Charles H Adler,Christopher S Coffey,Catherine M Kopil,Kuldip D Dave,Tatiana Foroud,Lana Chahine,Danna Jennings
Biomarkers in Medicine. 2017; 11(4): 359
[Pubmed]  [Google Scholar] [DOI]
21 Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinsonís Disease
Giorgio Vivacqua,Anna Latorre,Antonio Suppa,Michela Nardi,Sara Pietracupa,Romina Mancinelli,Giovanni Fabbrini,Carlo Colosimo,Eugenio Gaudio,Alfredo Berardelli,Philipp J. Kahle
PLOS ONE. 2016; 11(3): e0151156
[Pubmed]  [Google Scholar] [DOI]
22 Laboratory assessments in the course of Parkinsonís disease: a clinicianís perspective
Thomas MŁller,Horst Baas,Jan Kassubek,Peter Riederer,Peter Paul Urban,Christoph Schrader,Heinz Reichmann,Dirk Woitalla,Manfred Gerlach
Journal of Neural Transmission. 2016; 123(1): 65
[Pubmed]  [Google Scholar] [DOI]
23 Recent developments in circulating biomarkers in Parkinsonís disease: the potential use of miRNAs in a clinical setting
Marcia Cristina Teixeira dos Santos,Rosie Bell,Andre Nogueira da Costa
Bioanalysis. 2016; 8(23): 2497
[Pubmed]  [Google Scholar] [DOI]
24 Alpha-Synuclein as a Biomarker for Parkinsonśs Disease
Anzari Atik,Tessandra Stewart,Jing Zhang
Brain Pathology. 2016; 26(3): 410
[Pubmed]  [Google Scholar] [DOI]
25 Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases
Sahdeo Prasad,Amit K Tyagi,Bharat B Aggarwal
Experimental Biology and Medicine. 2016; 241(8): 783
[Pubmed]  [Google Scholar] [DOI]
26 Biomarker sources for Parkinsonśs disease: Time to shed tears?
M. BŲrger,S. Funke,M. Bšhr,F. Grus,P. Lingor
Basal Ganglia. 2015; 5(2-3): 63
[Pubmed]  [Google Scholar] [DOI]
27 Systematic review and meta-analysis of salivary protein concentration in Parkinsonśs disease
Joseph M. Masters,Jonathan Bestwick,Thomas T. Warner,Gavin Giovannoni,Gordon B. Proctor,Alastair J. Noyce
Movement Disorders. 2015; 30(14): 1971
[Pubmed]  [Google Scholar] [DOI]

 

Read this article